BRIEF published on 07/02/2025 at 13:05, 8 months 16 days ago Bausch Health to Release Q2 2025 Financial Results Conference Call Investor Relations Financial Announcement Bausch Health Q2 2025 Results
PRESS RELEASE published on 07/02/2025 at 13:00, 8 months 16 days ago Bausch Health to Announce Second Quarter 2025 Results on July 30 Bausch Health Companies Inc. to release Q2 2025 financial results on July 30, 2025, followed by a conference call and webcast at 5:00 p.m. U.S. EDT. Details and materials available on the investor relations website Financial Results Conference Call Investor Relations Webcast Bausch Health
BRIEF published on 05/14/2025 at 22:20, 10 months 4 days ago Bausch Health Announces Election Results and Approvals at 2025 Annual Meeting Bausch Health Annual Meeting Shareholder Vote Director Election Compensation Approval
PRESS RELEASE published on 05/14/2025 at 22:15, 10 months 4 days ago Bausch Health Announces 2025 Annual Meeting of Shareholder Results Bausch Health Companies Inc. announces election of 10 directors at 2025 annual meeting of shareholders and various approvals and appointments Shareholders Bausch Health Companies Inc. Compensation Annual Meeting Election Of Directors
BRIEF published on 05/06/2025 at 14:05, 10 months 12 days ago Xifaxan Reduces Risk of 30-Day Rehospitalization After OHE XIFAXAN Chronic Liver Disease OHE Rehospitalization Claims-Based Analysis Lactulose
PRESS RELEASE published on 05/06/2025 at 14:00, 10 months 12 days ago Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization New analysis shows Xifaxan efficacy in reducing OHE rehospitalizations regardless of prior treatment. Data presented at DDW 2025 XIFAXAN Bausch Health Gastroenterology OHE Rehospitalizations
BRIEF published on 04/30/2025 at 22:10, 10 months 18 days ago Bausch Health Reports First-Quarter 2025 Results Financial Results EBITDA Revenue Growth Bausch Health First Quarter 2025
PRESS RELEASE published on 04/30/2025 at 22:05, 10 months 18 days ago Bausch Health Announces First Quarter 2025 Results Bausch Health Companies Inc. reports strong first quarter 2025 financial results with revenue growth, successful refinancing, and favorable court ruling. Company remains focused on profitable growth and shareholder value Financial Results Revenue Growth Shareholder Value Bausch Health First Quarter 2025
BRIEF published on 04/29/2025 at 14:05, 10 months 19 days ago Bausch Health Secures Health Canada Approval for Thermage FLX Thermage FLX Bausch Health Health Canada Aesthetic Technology Skin Tightening
PRESS RELEASE published on 04/29/2025 at 14:00, 10 months 19 days ago Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System Health Canada approves Thermage FLX, the latest non-invasive skin tightening system from Bausch Health's Solta Medical. Features enhanced comfort, smart technology, and versatile applications Thermage FLX Bausch Health Health Canada Skin Tightening Solta Medical
Published on 03/19/2026 at 01:05, 1 hour 34 minutes ago Prospect Ridge Announces Closing of Flow-Through Share Private Placement
Published on 03/18/2026 at 23:45, 2 hours 54 minutes ago Orogen Royalties Announces Private Placement Update
Published on 03/18/2026 at 21:00, 5 hours 39 minutes ago PLDT's Smart Selects Amdocs to Transform Retail Operations with AI-Powered Store Genie
Published on 03/18/2026 at 19:05, 7 hours 34 minutes ago Deposit Modeling at Thor Shows that the Proven Thor Epithermal Deposit is Flanked on Both Sides by a Much Larger Deposit
Published on 03/18/2026 at 18:10, 8 hours 29 minutes ago Silver X Mining Closes C$69M Brokered Private Placement of Secured Convertible Debentures
Published on 03/18/2026 at 22:00, 4 hours 39 minutes ago aap successfully completes MDR certification: All existing products approved according to MDR – market access in the EU and CE-relevant markets secured in the long term
Published on 03/18/2026 at 18:53, 7 hours 46 minutes ago EQS-Adhoc: Formycon AG postpones the publication of its audited annual and consolidated financial statements for 2025
Published on 03/18/2026 at 18:37, 8 hours 2 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/18/2026 at 18:15, 8 hours 23 minutes ago Northern Data Group releases audited FY 2025 Financial Results
Published on 03/18/2026 at 19:41, 6 hours 58 minutes ago Covivio - Conditions of availability of the 2025 Universal Registration Document
Published on 03/18/2026 at 18:00, 8 hours 39 minutes ago Deezer achieves profitability in FY25 as strategy delivers tangible results
Published on 03/18/2026 at 17:45, 8 hours 54 minutes ago Infotel : 2025 full-year results. Launch of a new Infotel 2030 strategic plan. Revenue target of €500 million by 2030.
